BioSpace News Archive

Allucent, a global mid-sized clinical research organization, announced that it received a project award valued at $25.5 million through the Rapid Response Partnership Vehicle Consortium to conduct its Decentralized Home Focus COVID-19 Trial.

NORTH CHICAGO, ILLINOIS, May 15, 2024 — Rosalind Franklin University’s Helix 51 biomedical incubator, the only one of its kind in Lake County, Illinois, celebrated its fifth year of...

According to a new report by nova one advisor, the U.S. active pharmaceutical ingredient (API) market size was valued at USD 37.19 billion in 2023 and is anticipated to reach around USD 72.21 billion by 2033, growing at a CAGR of 6.86% from 2024 to 2033.

According to Vision Research Reports, the global cell signaling market size was estimated at USD 5.45 billion in 2023 and it is expected to grow at a CAGR of 7.58% from 2024 to 2033, to reach around...

Neuronetics, Inc. announced that Humana has become the first commercial payer to update its policy in response to the Company’s recent clearance from the U.S. Food and Drug Administration for NeuroStar TMS as a first-line add-on for adolescents aged 15-21 with MDD.

Enable Injections, Inc. and Serina Therapeutics announced a partnership to develop and commercialize SER-252 in combination with enFuse for the treatment of Parkinson’s disease.

Osmol Therapeutics today announced the appointment of Christopher S. Eklund, Managing Director and Partner at venture capital investment firm, J.W. Childs Associates, to its Board of Directors.

Tonix Pharmaceuticals Holding Corp. announced today that Seth Lederman, M.D., Chief Executive Officer, will participate virtually in a fireside chat at A.G.P.’s Healthcare Company Showcase on Tuesday, May 21, 2024, at 9:00 a.m. ET.

TC BioPharm PLC announced that the company’s lead therapeutic TCB008 will be available to patients via a newly launched compassionate use program in the UK.

Researchers from Lund University and Enable Biosciences announced significant findings from their latest collaborative study, revealing the superior performance of the automated multiplex Antibody Detection by Agglutination-PCR technology over traditional Radiobinding Assays in identifying early stages of Type 1 Diabetes.